How big is the Short-Read Sequencing Market?

The Short-Read Sequencing Market size is expected to reach USD 7.90 billion in 2024 and grow at a CAGR of 16.40% to reach USD 16.80 billion by 2029. Read More

What is the current Short-Read Sequencing Market size?

In 2024, the Short-Read Sequencing Market size is expected to reach USD 7.90 billion. Read More

Who are the key players in Short-Read Sequencing Market?

Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN, BGI (Beijing Genomics Institute) and Agilent Technologies are the major companies operating in the Short-Read Sequencing Market. Read More

Which is the fastest growing region in Short-Read Sequencing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Short-Read Sequencing Market?

In 2024, the North America accounts for the largest market share in Short-Read Sequencing Market. Read More

What years does this Short-Read Sequencing Market cover, and what was the market size in 2023?

In 2023, the Short-Read Sequencing Market size was estimated at USD 6.60 billion. The report covers the Short-Read Sequencing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Short-Read Sequencing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Short-Read Sequencing Market Share

Statistics for the 2023 & 2024 Short-Read Sequencing market share, created by Mordor Intelligence™ Industry Reports. Short-Read Sequencing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Short-Read Sequencing Industry

The short-read sequencing market is semi-consolidated due to only major players operating globally and regionally. The competitive landscape includes analyzing international companies with significant market share. Some of the major players in the market include Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, BGI (Beijing Genomics Institute), and Agilent Technologies.